Video

Juanita Madison Describes the Provenge Treatment Process

Author(s):

Juanita Madison, MN, RN

In Partnership With:

Juanita Madison from Seattle Cancer Care Alliance Describes the Provenge Treatment Process

Lead researcher Juanita Madison, MN, RN, AOCN from the Seattle Cancer Care Alliance (SCCA) discusses some of the findings from her research on the complexity of the provenge treatment process and how it involves several multidisciplinary teams as the immune cells go from leukapheresis, to a Dendreon manufacturing facility, and then back to the patient.

Related Videos
Ritu Salani, MD
Aaron Gerds, MD
Maximilian Stahl, MD
Abhirami Vivekanandarajah, MD
Balazs Halmos, MD
Balazs Halmos, MD
Ghayas C. Issa, MD
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Related Content
The FDA has approved cosibelimab-ipdl for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.
December 13th 2024

FDA Approves Cosibelimab for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Oncology Unplugged
August 7th 2024

Park and Grivas Expand on Treatment Updates in Bladder Cancer

Evolving Treatment Strategies: Managing Advanced Prostate Cancer
December 10th 2024

Evolving Treatment Strategies: Managing Advanced Prostate Cancer

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Diffuse Large B-cell Lymphoma | Image Credit: © LASZLO – stock.adobe.com
December 8th 2024

FS118 Showcases Modest Efficacy in Relapsed/Refractory DLBCL

Monica H. Vetter, MD
December 5th 2024

Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer